These results reflect that the mechanisms of PGC-1α inhibiting AD-related apoptosis and neurobehavioral abnormalities are likely through the improvement of mitochondrial dynamics, transport and dysfunction. This evidence concerns the gene PPARGC1A and Alzheimer disease.